港股详情

本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

药捷安康-B

176.200

-15.800-8.23%

成交量：257.35万

成交额：4.90亿

市值：699.51亿

市盈率：-224.55

高：210.000

开：198.800

低：175.300

收：192.000

52周最高：679.500

52周最低：20.200

股本：3.97亿

香港流通股本：3.02亿

量比：0.59

换手率：0.85%

股息：- -

股息率：- -

每股收益(LYR):-0.785

净资产收益率：-39.08%

总资产收益率：-21.10%

市净率：110.18

市盈率(LYR):-224.55

市销率: - -

数据加载中...

总览公司新闻公告

迈博药业-B盘中异动下午盘快速拉升6.41%报0.830港元

港股异动 | 药捷安康-B(02617.HK)早盘飙升近40% 公司正式进入港股通名单核心产品近期迎多重利好

港股生物医药股多数走强，药捷安康-B、映恩生物-B均创上市以来新高

老虎资讯综合

映恩生物-B、药捷安康-B均创上市以来新高！此前被调入港股通标的名单

老虎资讯综合

药捷安康-B早盘涨近11%创上市新高公司获纳入港股通名单

港股异动 | 药捷安康-B(02617.HK)涨超10% 股价刷新上市新高公司获纳入港股通名单

深港通下的港股通标的证券名单调整，今日起生效

老虎资讯综合

港股异动 | 药捷安康-B(02617.HK)涨超8%创新高替恩戈替尼联用开坦尼/依达方的II期临床试验完成首例患者给药

药捷安康-B(02617)：替恩戈替尼联用康方生物开坦尼®(卡度尼利，PD-1/CTLA-4)╱ 依达方®(依沃西，PD-1/VEGF)的II期临床试验完成首例患者给药

药捷安康-B09月03日主力净流出147.5万元散户资金买入

药捷安康－Ｂ(02617)股价上升8.495%，现价港币$58.75

阿斯达克财经

药捷安康-B08月29日主力净流入96.8万元散户资金抛售

港股生物医药股午后涨幅持续扩大！科笛-B涨超25%，荣昌生物涨超13%

老虎资讯综合

异动解读 | 港股药捷安康-B盘中大涨7.16%，生物医药板块普涨

【IPO前哨】天辰生物赴港：估值超20亿，研发烧钱何时休？

药捷安康中期业绩：其他收入及收益降幅超65% 税前亏损1.23亿元

异动解读 | 药捷安康-B盘中大跌5.02%，纳入恒生指数系列后业绩表现或不及预期

异动解读 | 药捷安康-B盘中大跌5.02%，疑似受中期业绩影响

药捷安康-B(02617)获纳入恒生指数系列成份股

药捷安康-B(02617.HK)发布中期业绩股东应占亏损1.23亿元同比收窄23.39%

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/stock/02617/news?page=6"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"02617","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02617\",,,,,undefined,":{"symbol":"02617","market":"HK","secType":"STK","nameCN":"药捷安康-B","latestPrice":176.2,"timestamp":1761197361623,"preClose":192,"halted":0,"volume":2573501,"delay":0,"floatShares":301666673,"shares":397000000,"eps":-0.7846823312971165,"marketStatus":"交易中","change":-15.8,"latestTime":"10-23 13:29:40","open":198.8,"high":210,"low":175.3,"amount":489571692,"amplitude":0.180729,"askPrice":176.2,"askSize":2500,"bidPrice":176,"bidSize":1000,"shortable":0,"etf":0,"ttmEps":-0.6769405737778813,"tradingStatus":2,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1761207000000},"marketStatusCode":2,"adr":0,"listingDate":1750608000000,"exchange":"SEHK","adjPreClose":192,"openAndCloseTimeList":[[1761183000000,1761192000000],[1761195600000,1761206400000]],"volumeRatio":0.5889,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02617\",,,,,undefined,":{"symbol":"02617","floatShares":301666673,"roa":"-21.10%","roe":"-39.08%","lyrEps":-0.784682,"volumeRatio":0.5889,"shares":397000000,"dividePrice":0,"high":210,"amplitude":0.180729,"preClose":192,"low":175.3,"week52Low":20.2,"pbRate":"110.18","week52High":679.5,"institutionHeld":0,"latestPrice":176.2,"committee":-0.428571,"eps":-0.7846823312971165,"divideRate":0,"volume":2573501,"delay":0,"ttmEps":-0.6769405737778813,"open":198.8,"prevYearClose":13.15,"prevWeekClose":203,"prevMonthClose":141.2,"prevQuarterClose":141.2,"fiveDayClose":166.1,"twentyDayClose":165.1,"sixtyDayClose":40.9},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/02617\",params:#limit:5,,,undefined,":[{"date":"2025-08-25","symbol":"02617","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1756085400000,"name":null,"time":"","dateTimestamp":1756051200000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"02617\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"02617\",market:\"HK\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/02617\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"02617","date":"2025-10-22","current":-260.288727,"percent":0.035294,"low":-380.446233,"twenty":-191.456594,"median":-60.667237,"eighty":-42.017389,"high":-17.403134,"avg":-105.13191,"sd":84.561944,"marketCap":76204345536},"quantilePoints":[{"date":"2025-06-20","current":-17.403134,"twenty":-17.403134,"median":-17.403134,"eighty":-17.403134,"marketCap":5219203873},{"date":"2025-06-27","current":-36.622688,"twenty":-34.709071,"median":-32.493198,"eighty":-31.066553,"marketCap":11013909315},{"date":"2025-07-04","current":-44.802949,"twenty":-38.622694,"median":-35.660049,"eighty":-31.776499,"marketCap":13474674640},{"date":"2025-07-11","current":-39.630155,"twenty":-40.38446,"median":-38.336544,"eighty":-32.816725,"marketCap":11906928990},{"date":"2025-07-18","current":-43.957869,"twenty":-42.111612,"median":-39.630155,"eighty":-34.373739,"marketCap":13196846297},{"date":"2025-07-25","current":-49.067594,"twenty":-42.195906,"median":-40.285196,"eighty":-36.230637,"marketCap":14784436829},{"date":"2025-08-01","current":-50.963195,"twenty":-45.655878,"median":-41.371359,"eighty":-36.620356,"marketCap":15260713988},{"date":"2025-08-08","current":-58.015216,"twenty":-51.234741,"median":-42.017389,"eighty":-37.993773,"marketCap":17415868136},{"date":"2025-08-15","current":-66.867935,"twenty":-57.065221,"median":-42.261724,"eighty":-38.707864,"marketCap":20043330466},{"date":"2025-08-22","current":-72.723484,"twenty":-59.09189,"median":-43.957869,"eighty":-39.464263,"marketCap":21730145406},{"date":"2025-08-29","current":-49.610789,"twenty":-64.458089,"median":-47.896219,"eighty":-39.630155,"marketCap":21492006826},{"date":"2025-09-05","current":-57.867887,"twenty":-63.405379,"median":-50.300475,"eighty":-39.739866,"marketCap":25044240642},{"date":"2025-09-12","current":-176.221101,"twenty":-67.557018,"median":-51.642061,"eighty":-40.181616,"marketCap":76402794352},{"date":"2025-09-19","current":-137.321051,"twenty":-71.134174,"median":-54.042597,"eighty":-40.68225,"marketCap":59494955186},{"date":"2025-09-26","current":-219.814439,"twenty":-72.736767,"median":-55.62397,"eighty":-41.23574,"marketCap":56835741045},{"date":"2025-10-03","current":-208.418403,"twenty":-113.88308,"median":-57.213624,"eighty":-41.375772,"marketCap":54017767851},{"date":"2025-10-10","current":-183.264838,"twenty":-172.633767,"median":-57.790453,"eighty":-41.583173,"marketCap":47429267143},{"date":"2025-10-17","current":-311.562728,"twenty":-178.967921,"median":-58.015216,"eighty":-41.927636,"marketCap":80570219499},{"date":"2025-10-22","current":-294.68471,"twenty":-191.456594,"median":-60.667237,"eighty":-42.017389,"marketCap":76204345536}],"updateTime":1761197380130},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"02617\",pageSize:20,pageCount:6,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2566763106","title":"迈博药业-B盘中异动 下午盘快速拉升6.41%报0.830港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2566763106","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2566763106?lang=zh_cn&edition=fundamental","pubTime":"2025-09-10 13:30","pubTimestamp":1757482248,"startTime":"0","endTime":"0","summary":"2025年09月10日下午盘13时30分，迈博药业-B股票出现波动，股价快速上涨6.41%。截至发稿，该股报0.830港元/股，成交量36.2万股，换手率0.01%，振幅10.26%。资金方面，该股资金流入1660港元，流出27.652万港元。迈博药业-B股票所在的生物技术行业中，整体涨幅为0.02%。迈博药业-B公司简介：迈博药业有限公司是一家主要从事癌症及自身免疫性疾病的单抗药物的研究、开发及生产的投资控股公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025091013304895203c87&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025091013304895203c87&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02617","02181","BK1574","06628","02257","BK1161"],"gpt_icon":0},{"id":"2566238126","title":"港股异动 | 药捷安康-B(02617.HK)早盘飙升近40% 公司正式进入港股通名单 核心产品近期迎多重利好","url":"https://stock-news.laohu8.com/highlight/detail?id=2566238126","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2566238126?lang=zh_cn&edition=fundamental","pubTime":"2025-09-10 10:01","pubTimestamp":1757469718,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["HSCEI","02617","BK1161","BK4614","07226","YANG"],"gpt_icon":0},{"id":"1165674703","title":"港股生物医药股多数走强，药捷安康-B、映恩生物-B均创上市以来新高","url":"https://stock-news.laohu8.com/highlight/detail?id=1165674703","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1165674703?lang=zh_cn&edition=fundamental","pubTime":"2025-09-10 09:51","pubTimestamp":1757469078,"startTime":"0","endTime":"0","summary":"9月10日，港股生物医药股多数走强，$药捷安康-B(02617)$飙涨近40%，$映恩生物-B(09606)$涨超11%，均创上市以来新高。","market":"hk","thumbnail":"https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"5aaec95b07afdce68b3c101ed62a5f7d","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4614","02617","09606"],"gpt_icon":0},{"id":"1167675110","title":"映恩生物-B、药捷安康-B均创上市以来新高！此前被调入港股通标的名单","url":"https://stock-news.laohu8.com/highlight/detail?id=1167675110","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1167675110?lang=zh_cn&edition=fundamental","pubTime":"2025-09-08 10:46","pubTimestamp":1757299574,"startTime":"0","endTime":"0","summary":"9月8日，$映恩生物-B(09606)$涨幅扩大至18%、$药捷安康-B(02617)$涨幅扩大至20%，均创上市以来新高！此前被调入港股通标的名单。","market":"hk","thumbnail":"https://static.tigerbbs.com/fd680cd945fd32917c8ece66ec685e5f","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/fd680cd945fd32917c8ece66ec685e5f"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"2ea7ccd6a31b3cd6d3ea988a9ba76c8b","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","HK0000252160.HKD","07226","LU2543165471.USD","02617","YANG","HSCEI","HK0000500386.USD","HSTECH","BK4614","HK0000252152.HKD","09606"],"gpt_icon":0},{"id":"2565792105","title":"药捷安康-B早盘涨近11%创上市新高 公司获纳入港股通名单","url":"https://stock-news.laohu8.com/highlight/detail?id=2565792105","media":"新浪港股","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2565792105?lang=zh_cn&edition=fundamental","pubTime":"2025-09-08 10:19","pubTimestamp":1757297940,"startTime":"0","endTime":"0","summary":"　　药捷安康-B早盘涨超10%，盘中高见78港元，刷新上市新高。截至发稿，涨10.54%，报69.75港元，成交额5433.80万港元。　　上交所、深交所发布公告，药捷安康被调入港股通标的名单，自9月8日起生效。此外，药捷安康近日宣布，公司核心产品替恩戈替尼分别联用康方生物科技（开曼）有限公司开坦尼╱依达方的治疗晚期肝细胞癌的开放性、多中心II期临床研究，于近日完成首例患者给药。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"2ea7ccd6a31b3cd6d3ea988a9ba76c8b","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/marketalerts/2025-09-08/doc-infptvcs6432941.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK4614","HSTECH","YANG","BK1161","02617"],"gpt_icon":0},{"id":"2565457931","title":"港股异动 | 药捷安康-B(02617.HK)涨超10% 股价刷新上市新高 公司获纳入港股通名单","url":"https://stock-news.laohu8.com/highlight/detail?id=2565457931","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2565457931?lang=zh_cn&edition=fundamental","pubTime":"2025-09-08 09:54","pubTimestamp":1757296496,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"2ea7ccd6a31b3cd6d3ea988a9ba76c8b","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK1161","02617","07226","BK4614","YANG","HSCEI"],"gpt_icon":0},{"id":"1193205128","title":"深港通下的港股通标的证券名单调整，今日起生效","url":"https://stock-news.laohu8.com/highlight/detail?id=1193205128","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1193205128?lang=zh_cn&edition=fundamental","pubTime":"2025-09-08 08:56","pubTimestamp":1757293007,"startTime":"0","endTime":"0","summary":"9月8日，深交所公告，因恒生综合大型股指数、中型股指数、小型股指数实施成份股定期调整，根据《深圳证券交易所深港通业务实施办法》的有关规定，港股通标的证券名单发生调整并自2025年09月08日起生效，相关调整信息如下。","market":"us","thumbnail":"https://static.tigerbbs.com/e68f18a297e419bae3cc0320b6d8ff4e","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/e68f18a297e419bae3cc0320b6d8ff4e"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"250fd3c19b1c3295bf89a5ea42553b13","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":"深港通下的港股通标的证券名单调整，今日起生效","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03677","06681","02643","09606","06168","09678","02617","02007"],"gpt_icon":0},{"id":"2565471530","title":"港股异动 | 药捷安康-B(02617.HK)涨超8%创新高 替恩戈替尼联用开坦尼/依达方的II期临床试验完成首例患者给药","url":"https://stock-news.laohu8.com/highlight/detail?id=2565471530","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2565471530?lang=zh_cn&edition=fundamental","pubTime":"2025-09-05 15:55","pubTimestamp":1757058953,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK1161","02617"],"gpt_icon":0},{"id":"2564607303","title":"药捷安康-B(02617)：替恩戈替尼联用康方生物开坦尼®(卡度尼利，PD-1/CTLA-4)╱ 依达方®(依沃西，PD-1/VEGF)的II期临床试验完成首例患者给药","url":"https://stock-news.laohu8.com/highlight/detail?id=2564607303","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2564607303?lang=zh_cn&edition=fundamental","pubTime":"2025-09-04 22:38","pubTimestamp":1756996699,"startTime":"0","endTime":"0","summary":"智通财经APP讯，药捷安康-B 发布公告，公司核心产品替恩戈替尼分别联用康方生物科技(开曼)有限公司开坦尼╱依达方的治疗晚期肝细胞癌的开放性、多中心II期临床研究，于近日完成首例患者给药。该试验的主要目标人群为既往未接受过针对肝细胞癌的全身抗肿瘤治疗或既往标准治疗失败后的晚期肝细胞癌患者。药捷安康已与康方生物订立合作协议，双方共同针对肝细胞癌领域开展临床联合用药开发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1341719.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["IE00B543WZ88.USD","LU2476274308.USD","LU0540923850.HKD","LU0348766576.USD","BK4023","LU0348825331.USD","LU2476274720.SGD","LU0348784397.USD","LU0348735423.USD","LU0348783233.USD","IE00BPRC5H50.USD","LU0417516571.SGD","LU0417516902.SGD","BK1161","LU1794554557.SGD","LU0348827113.USD","IE00B5MMRT66.SGD","LU1169590202.USD","LU0561508036.HKD","PD","LU1169589451.USD","LU0634319403.HKD","LU2488822045.USD","LU2778985437.USD","LU0417516738.SGD","BK1574","LU0348767384.USD","02617","LU1720050803.USD"],"gpt_icon":1},{"id":"2564307395","title":"药捷安康-B09月03日主力净流出147.5万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2564307395","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2564307395?lang=zh_cn&edition=fundamental","pubTime":"2025-09-03 16:15","pubTimestamp":1756887314,"startTime":"0","endTime":"0","summary":"09月03日, 药捷安康-B股价跌4.98%，报收60.05元，成交金额751.0万元，换手率0.04%，振幅6.33%，量比0.77。药捷安康-B今日主力资金净流出147.5万元，上一交易日主力净流入65.7万元。该股近5个交易日上涨11.72%，主力资金累计净流入14.9万元；近20日主力资金累计净流入136.8万元，其中净流入天数为6日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250903165536a4b173df&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250903165536a4b173df&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02617","BK1161"],"gpt_icon":0},{"id":"2564389827","title":"药捷安康－Ｂ(02617)股价上升8.495%，现价港币$58.75","url":"https://stock-news.laohu8.com/highlight/detail?id=2564389827","media":"阿斯达克财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2564389827?lang=zh_cn&edition=fundamental","pubTime":"2025-09-01 11:59","pubTimestamp":1756699140,"startTime":"0","endTime":"0","summary":"[上升股]药捷安康－Ｂ(02617) 股价在上午11:59比前收市价上升8.495%，现股价为港币$58.75。至目前为止，今日最高价为$58.75，而最低价为$54.15。总成交量为8.108万股，总成交金额为港币$459.74万。","market":"hk","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20180112133338093_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20180112133338093_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAR2509014244/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["02617","BK1161"],"gpt_icon":0},{"id":"2563072305","title":"药捷安康-B08月29日主力净流入96.8万元 散户资金抛售","url":"https://stock-news.laohu8.com/highlight/detail?id=2563072305","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2563072305?lang=zh_cn&edition=fundamental","pubTime":"2025-08-29 16:15","pubTimestamp":1756455333,"startTime":"0","endTime":"0","summary":"08月29日, 药捷安康-B股价涨6.18%，报收54.15元，成交金额1069.2万元，换手率0.07%，振幅11.96%，量比0.99。药捷安康-B今日主力资金净流入96.8万元，上一交易日主力净流出0万元。该股近5个交易日下跌1.19%，主力资金累计净流入96.8万元；近20日主力资金累计净流入265.9万元，其中净流入天数为6日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250829171813a703a166&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250829171813a703a166&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02617"],"gpt_icon":0},{"id":"1181795703","title":"港股生物医药股午后涨幅持续扩大！科笛-B涨超25%，荣昌生物涨超13%","url":"https://stock-news.laohu8.com/highlight/detail?id=1181795703","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1181795703?lang=zh_cn&edition=fundamental","pubTime":"2025-08-29 13:05","pubTimestamp":1756443930,"startTime":"0","endTime":"0","summary":"8月29日，港股生物医药股盘中走高，$科笛-B(02487)$涨超12%，$和铂医药-B(02142)$涨超9%，$荣昌生物(09995)$、$药捷安康-B(02617)$、$科济药业-B(02171)$涨超6%，$药明生物(02269)$涨超5%。","market":"hk","thumbnail":"https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"c3254beb3708cecfea7110f8c44bea74","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1521","02142","161726","09995","LU0823426308.USD","LU0348735423.USD","LU0856984785.SGD","02617","02487","YANG","02269","BK4614","BK1161","LU0588546209.SGD","HSTECH","LU1880383366.USD","HSCEI","LU1242518931.SGD","09939","399441","LU0417516738.SGD","LU0359201612.USD","07226","02171"],"gpt_icon":0},{"id":"1168027816","title":"异动解读 | 港股药捷安康-B盘中大涨7.16%，生物医药板块普涨","url":"https://stock-news.laohu8.com/highlight/detail?id=1168027816","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1168027816?lang=zh_cn&edition=fundamental","pubTime":"2025-08-29 10:26","pubTimestamp":1756434388,"startTime":"0","endTime":"0","summary":"今日盘中，港股生物医药板块整体走强，其中药捷安康-B（02617）表现突出，股价大涨7.16%，引发市场关注。\n\n除药捷安康-B外，多只生物医药股同步走高。科笛-B（02487）涨幅最为显著，超过12%；和铂医药-B（02142）紧随其后，涨幅超过9%。此外，荣昌生物（09995）、科济药业-B（02171）涨幅均超过6%，药明生物（02269）也上涨超过5%。\n\n生物医药板块的集体上涨反映了投资者对该行业的积极预期。作为该板块的重要成员，药捷安康-B的强劲表现不仅体现了公司自身的发展潜力，也反映了整个行业的向好趋势。投资者可持续关注该板块的后续发展动向。","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"c3254beb3708cecfea7110f8c44bea74","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["02617"],"gpt_icon":0},{"id":"2562218467","title":"【IPO前哨】天辰生物赴港：估值超20亿，研发烧钱何时休？","url":"https://stock-news.laohu8.com/highlight/detail?id=2562218467","media":"财华社","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2562218467?lang=zh_cn&edition=fundamental","pubTime":"2025-08-27 15:23","pubTimestamp":1756279396,"startTime":"0","endTime":"0","summary":"今年以来，包括药捷安康-B（02617.HK）、维立志博-B（09887.HK）、中慧生物-B（02627.HK）、银诺医药-B（02591.HK）在内的众多生物科技企业通过第18A章登陆了港股市场，其中一些生物科技股在上市后有着非常亮眼的表现。","market":"other","thumbnail":"https://images.finet.hk/photoLib/title/202508_1/a2dd3e09-1100-4ccc-82d8-cbdc3f3e7b19.png","type":0,"news_type":0,"thumbnails":["https://images.finet.hk/photoLib/title/202508_1/a2dd3e09-1100-4ccc-82d8-cbdc3f3e7b19.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.finet.hk/newscenter/news_content/68aeb264230829534078cedd","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"finet_stock","symbols":["BK1161","02627","02591","09887","BK4213","AR","02617"],"gpt_icon":0},{"id":"2562200822","title":"药捷安康中期业绩：其他收入及收益降幅超65% 税前亏损1.23亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2562200822","media":"财中社","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2562200822?lang=zh_cn&edition=fundamental","pubTime":"2025-08-26 14:41","pubTimestamp":1756190495,"startTime":"0","endTime":"0","summary":"8月25日，药捷安康（02617）发布截至2025年6月30日止6个月的中期业绩公告。公司在该期间的其他收入及收益由2024年的1040万元下降至360万元，降幅达到65.1%。此下降主要是由于银行存款利息及理财收入减少410万元，政府补助减少270万元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202508263494814389.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["02617","BK1161"],"gpt_icon":0},{"id":"1161848352","title":"异动解读 | 药捷安康-B盘中大跌5.02%，纳入恒生指数系列后业绩表现或不及预期","url":"https://stock-news.laohu8.com/highlight/detail?id=1161848352","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1161848352?lang=zh_cn&edition=fundamental","pubTime":"2025-08-26 10:14","pubTimestamp":1756174475,"startTime":"0","endTime":"0","summary":"港股药捷安康-B今日盘中大跌5.02%，引发市场关注。该公司此前刚刚宣布将被纳入多个恒生指数系列成份股，但股价却出现大幅下跌。根据公司公告，药捷安康-B将于2025年9月8日起被纳入恒生综合指数、恒生医疗保健指数、恒生创新药指数等多个恒生指数系列。另一方面，药捷安康-B近日公布了截至2025年6月底的中期业绩。分析人士认为，尽管公司被纳入重要指数，但其当前的财务状况可能不及市场预期，导致股价出现较大幅度的调整。","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["02617"],"gpt_icon":0},{"id":"1100059125","title":"异动解读 | 药捷安康-B盘中大跌5.02%，疑似受中期业绩影响","url":"https://stock-news.laohu8.com/highlight/detail?id=1100059125","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1100059125?lang=zh_cn&edition=fundamental","pubTime":"2025-08-26 10:14","pubTimestamp":1756174471,"startTime":"0","endTime":"0","summary":"港股药捷安康-B今日盘中大跌5.02%，引发市场关注。此次股价下跌可能与公司近期发布的中期业绩报告有关。根据公司公告，药捷安康-B发布了截至2025年6月止的六个月中期业绩。报告显示，公司亏损收窄至1.23亿元人民币，相比去年同期的1.6亿元有所改善。这一消息本应对公司股价产生积极影响，但似乎未能抵消中期业绩带来的负面影响。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["02617"],"gpt_icon":0},{"id":"2562228505","title":"药捷安康-B(02617)获纳入恒生指数系列成份股","url":"https://stock-news.laohu8.com/highlight/detail?id=2562228505","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2562228505?lang=zh_cn&edition=fundamental","pubTime":"2025-08-25 22:34","pubTimestamp":1756132485,"startTime":"0","endTime":"0","summary":"智通财经APP讯，药捷安康-B(02617)发布公告，根据恒生指数有限公司于2025年8月22日公布的恒生指数系列季度检讨结果，公司已获选并将纳入包括但不限于下述恒生指数系列成份股，自2025年9月8日起生效：1.恒生综合指数;2.恒生综合行业指数-医疗保健业;3.恒生综合中小型股指数;4.恒生综合小型股指数;5.恒生医疗保健指数;6.恒生创新药指数;7.恒生港股通创新药指数;8.恒生港股通创新药精选指数;及9.恒生港股通药品及生物技术(可投资)指数。公告称，公司获纳入恒生综合指数及上述指数反映投资者的认可度上升。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1334891.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["HSI","02617","02833","HHImain","513600","BK1161","MCHmain","HSImain","159271","MHImain"],"gpt_icon":0},{"id":"2562416612","title":"药捷安康-B(02617.HK)发布中期业绩 股东应占亏损1.23亿元 同比收窄23.39%","url":"https://stock-news.laohu8.com/highlight/detail?id=2562416612","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2562416612?lang=zh_cn&edition=fundamental","pubTime":"2025-08-25 20:22","pubTimestamp":1756124552,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["MUCmain","UCmain","02617","BK1161","CNHmain","MCNHmain","CYB"],"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":6,"totalSize":181,"code":"91000000","status":"200"}]}}